Key facts
- This page summarizes B. Lynne Parshall's Form 4 filing for Foghorn Therapeutics Inc. (FHTX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 25 Jun 2026, 16:01.
B. Lynne Parshall - 24 Jun 2026 Form 4 Insider Report for Foghorn Therapeutics Inc. (FHTX)
- Reporting relationship
- Director
- Issuer ticker
- FHTX
- Reported as of
- 24 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 25 Jun 2026, 16:01:18 UTC
- Prior SEC filing
- 01 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael LaCascia, Attorney-in-Fact for B. Lynne Parshall
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
B. Lynne Parshall filed Form 4 for Foghorn Therapeutics Inc. (FHTX) on 25 Jun 2026.
Change
- Previous filing in this sequence was filed on 01 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001073385
Primary reporting owner
PARSHALL B LYNNE
- Relationship
- Director
- Address
- 99 COOLIDGE AVENUE, STE 500, WATERTOWN
- Signature
- /s/ Michael LaCascia, Attorney-in-Fact for B. Lynne Parshall
- Signature date
- 25 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FHTX
transaction
Derivative
Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +28,000
- Change %
- Price
- $4.08*
- Shares after
- 28,000
- Date
- 24 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,000
- Exercise price
- $4.08
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors.